MedTrace Logo

The Hepatitis Delta International Network

NCT02375906 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2022-06-02

No results posted yet for this study

Summary

Hepatitis delta is a major health problem, not only because of the severity of the disease, but also due to the lack of effective antiviral treatment. To improve the current therapeutic options, a better understanding of the pathophysiology is essential. Reliable research in this direction is only possible with large patient study groups. However, given the geographic distribution of hepatitis delta, larger patient cohorts would only be possible through multicenter collaboration.

Conditions

  • Hepatitis D

Sponsors & Collaborators

  • German Center for Infection Research

    collaborator OTHER

  • Hannover Medical School

    collaborator OTHER

  • HepNet Study House, German Liverfoundation

    lead NETWORK

Principal Investigators

  • Michael P Manns, Prof. Dr. · Hannover Medical School

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2022-05-31
Completion
2022-05-31

Countries

  • Austria
  • Belgium
  • Brazil
  • Georgia
  • Germany
  • Greece
  • Italy
  • Moldova
  • Pakistan
  • Romania
  • Spain
  • Vietnam

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02375906 on ClinicalTrials.gov